Uterine estrogen receptor in vivo: phosphorylation of nuclear specific forms on serine residues - PubMed (original) (raw)
Uterine estrogen receptor in vivo: phosphorylation of nuclear specific forms on serine residues
T Washburn et al. Mol Endocrinol. 1991 Feb.
Abstract
We have characterized further the heterogeneous nuclear-specific doublet forms of the mouse uterine estrogen receptor (ER). Estrogen treatment produced the multiple nuclear ER forms of 65 and 66.5 kDa, which were isolated and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Soluble ER preparations exhibited only a single 65-kDa form. Isolation of the individual nuclear ER forms and reanalysis demonstrated that formation of the multiple bands was not due to artifacts of nuclear sample preparation or the presence of contaminating proteins. Analysis of individual uterine cell types (epithelial and stromal/myometrium) indicated that both ER forms were present in both cell fractions. Fractionation of nuclear components with low salt showed that both ER forms were found in the salt-resistant fraction. Extraction of nuclei with high salt (0.6 M KCl) solubilized both ER forms. Phosphorylation was studied as a protein modification to account for the multiple forms. Incorporation of 32P into uterine protein both in vivo and in intact tissue incubation indicated 32P labeling of uterine nuclear ER after hormone treatment. Both nuclear ER forms are labeled, although the 66.5-kDa form appears to be more heavily labeled. Phosphoamino acid analysis of the immunopurified 32P-labeled ER from intact uterine tissue indicated phosphoserine as the only phospholabeled residue. These data suggest that phosphorylation is associated with the physiological functioning of the ER in response to hormone and produces the heterogeneous ER forms in the nucleus.
Similar articles
- Multiple forms of affinity-labeled estrogen receptors in rat distinct pituitary cells.
Geffroy-Roisne S, Duval J, Thieulant ML. Geffroy-Roisne S, et al. Endocrinology. 1992 Sep;131(3):1503-10. doi: 10.1210/endo.131.3.1505480. Endocrinology. 1992. PMID: 1505480 - Differential response of individual uterine cell types from immature rats treated with estradiol.
McCormack SA, Glasser SR. McCormack SA, et al. Endocrinology. 1980 May;106(5):1634-49. doi: 10.1210/endo-106-5-1634. Endocrinology. 1980. PMID: 6153974 - Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo.
Nardulli AM, Katzenellenbogen BS. Nardulli AM, et al. Endocrinology. 1986 Nov;119(5):2038-46. doi: 10.1210/endo-119-5-2038. Endocrinology. 1986. PMID: 3533520 - Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor.
Joel PB, Traish AM, Lannigan DA. Joel PB, et al. Mol Endocrinol. 1995 Aug;9(8):1041-52. doi: 10.1210/mend.9.8.7476978. Mol Endocrinol. 1995. PMID: 7476978
Cited by
- Protein kinase A activation of glucocorticoid-mediated signaling in the developing retina.
Zhang H, Li YC, Young AP. Zhang H, et al. Proc Natl Acad Sci U S A. 1993 May 1;90(9):3880-4. doi: 10.1073/pnas.90.9.3880. Proc Natl Acad Sci U S A. 1993. PMID: 8097880 Free PMC article. - Estrogen receptor alpha (ERalpha) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium.
Hermon TL, Moore AB, Yu L, Kissling GE, Castora FJ, Dixon D. Hermon TL, et al. Virchows Arch. 2008 Dec;453(6):557-69. doi: 10.1007/s00428-008-0679-5. Epub 2008 Oct 14. Virchows Arch. 2008. PMID: 18853184 Free PMC article. - Estrogen Receptor Alpha Splice Variants, Post-Translational Modifications, and Their Physiological Functions.
Saito K, Cui H. Saito K, et al. Cells. 2023 Mar 14;12(6):895. doi: 10.3390/cells12060895. Cells. 2023. PMID: 36980236 Free PMC article. Review. - Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region.
Ali S, Metzger D, Bornert JM, Chambon P. Ali S, et al. EMBO J. 1993 Mar;12(3):1153-60. doi: 10.1002/j.1460-2075.1993.tb05756.x. EMBO J. 1993. PMID: 8458328 Free PMC article. - Mechanisms of hormone resistance in breast cancer.
Horwitz KB. Horwitz KB. Breast Cancer Res Treat. 1993;26(2):119-30. doi: 10.1007/BF00689685. Breast Cancer Res Treat. 1993. PMID: 8219249 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources